SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001108205-24-000008
Filing Date
2024-02-08
Accepted
2024-02-08 08:01:02
Documents
16
Period of Report
2024-02-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cris-20240208.htm   iXBRL 8-K 30357
2 EX-99.1 a4q23earningspressrelease.htm EX-99.1 74745
6 image_0a.jpg GRAPHIC 13933
  Complete submission text file 0001108205-24-000008.txt   264620

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cris-20240208.xsd EX-101.SCH 1908
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cris-20240208_lab.xml EX-101.LAB 24851
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cris-20240208_pre.xml EX-101.PRE 13054
18 EXTRACTED XBRL INSTANCE DOCUMENT cris-20240208_htm.xml XML 3009
Mailing Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421 617-503-6500
CURIS INC (Filer) CIK: 0001108205 (see all company filings)

IRS No.: 043505116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30347 | Film No.: 24606910
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)